GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (FRA:G09) » Definitions » ROE % Adjusted to Book Value

Genomic Vision (FRA:G09) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Genomic Vision ROE % Adjusted to Book Value?

Genomic Vision's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Genomic Vision's PB Ratio for the quarter that ended in Jun. 2023 was N/A. Genomic Vision's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.


Genomic Vision ROE % Adjusted to Book Value Historical Data

The historical data trend for Genomic Vision's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision ROE % Adjusted to Book Value Chart

Genomic Vision Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -179.46 -29.67 -12.82 -40.97 -

Genomic Vision Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.77 -39.58 -34.03 - -

Competitive Comparison of Genomic Vision's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Genomic Vision's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomic Vision's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genomic Vision's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Genomic Vision's ROE % Adjusted to Book Value falls into.



Genomic Vision ROE % Adjusted to Book Value Calculation

Genomic Vision's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-762.49% / N/A
=N/A

Genomic Vision's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomic Vision ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Genomic Vision's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomic Vision (FRA:G09) Business Description

Traded in Other Exchanges
N/A
Address
80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220
Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.

Genomic Vision (FRA:G09) Headlines

No Headlines